
---
title: '新冠检测、新冠特效药板块开盘领跌'
categories: 
 - 新媒体
 - 36kr
 - 快讯
headimg: 'https://picsum.photos/400/300?random=6101'
author: 36kr
comments: false
date: Wed, 19 Jan 2022 01:31:28 GMT
thumbnail: 'https://picsum.photos/400/300?random=6101'
---

<div>   
36氪获悉，新冠检测、新冠特效药板块开盘领跌，截至发稿，九安医疗、明德生物一字跌停，济民医疗、奥泰生物、科华生物、拓新药业、精华制药等跌幅居前。  
</div>
            